Eisai and Ono Pharma to conduct Phase Ib combination trial for liver cancer
Eisai and Ono Pharmaceutical are planning to conduct a Phase Ib clinical trial of Lenvima (lenvatinib mesylate) in combination with Opdivo (nivolumab), as part of their collaboration agreement to jointly develop the therapy for hepatocellular carcino …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | Liver | Pharmaceuticals | Urology & Nephrology